Spectrum Science’s Post

https://lnkd.in/dy_TSH3m 🌟 Bridging Gaps, Transforming Healthcare: Embrace Diversity in Clinical Trials! By fostering inclusivity, we unlock new insights, drive innovation, and ensure treatments work for everyone. Join the movement for a more equitable and effective healthcare system. #ClinicalTrials #DiversityInResearch #HealthEquity #InclusiveHealthcare 🚀💊

Diversity in clinical trials is not just a 'nice-to-have', but a necessity. Companies are launching innovative strategies to increase participation rates among diverse populations. https://bit.ly/3tTsTpD #HealthcareLeadership #ClinicalResearch #DiversityandInclusion

⚡ 𝟑𝟎𝐭𝐡 𝐀𝐧𝐧𝐢𝐯𝐞𝐫𝐬𝐚𝐫𝐲 𝐨𝐟 𝐭𝐡𝐞 𝐈𝐧𝐭𝐞𝐫𝐧𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐁𝐚𝐜𝐤 & 𝐍𝐞𝐜𝐤 𝐏𝐚𝐢𝐧 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐅𝐨𝐫𝐮𝐦! The members of the local organising committee are delighted to announce that the 𝟏𝟗𝐭𝐡 𝐈𝐧𝐭𝐞𝐫𝐧𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐅𝐨𝐫𝐮𝐦 𝐟𝐨𝐫 𝐁𝐚𝐜𝐤 𝐚𝐧𝐝 𝐍𝐞𝐜𝐤 𝐏𝐚𝐢𝐧 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐢𝐧 𝐏𝐫𝐢𝐦𝐚𝐫𝐲 𝐂𝐚𝐫𝐞 (𝐈𝐁𝐍𝐏 𝐅𝐨𝐫𝐮𝐦 𝟐𝟎𝟐𝟓) will be held 24 to 27 June 2025, in the beautiful mountain setting of #Davos, Switzerland. The overarching theme of Forum XIX is ‘𝐹𝑜𝑠𝑡𝑒𝑟𝑖𝑛𝑔 𝑀𝑢𝑠𝑐𝑢𝑙𝑜𝑠𝑘𝑒𝑙𝑒𝑡𝑎𝑙 𝐻𝑒𝑎𝑙𝑡ℎ 𝐼𝑚𝑝𝑎𝑐𝑡’. How can we better link across the pyramid of health influences for more effective clinical and public health action on the global challenge of back and neck pain? The theme aims to foster active participation, meaningful exchange, intersectoral engagement, and is intended to be discipline neutral. Delegates are encouraged to explore new, original ideas that bring researchers, clinicians, patients, policymakers, and knowledge-users from around the world together to reduce the global burden of back and neck pain. For further information on important dates and abstract submission please contact: antonia.banti@uzh.ch!

They're the themes at the foundation of everything we do, so it's great to see health equity and inclusive trial design spotlighted by our Chief Clinical Officer Athena Robinson PhD in this important discussion today at #DTxWest. #digitaltherapeutics #digitalhealth #dtx

Increasing diversity in clinical trials and all research is vital in understanding how health interventions can affect patients differently. Altura CEO Pete Fronte, MBA chaired a forum on this topic at the DIA 2024 Global Annual Meeting in June. Dr. Karen Correa, PhD,BCMAS, Takeda; Dr. Jim Schultz, Neighborhood Healthcare; and clinical trial patient Mario DuCre discussed how community health centers (CHCs) and life science companies can play a key role in boosting clinical study involvement among underrepresented populations. View the presentation: #diversity #healthequity #clinicalresearch #chcs #lifesciences

Check out "Why Clinical Evidence in #DigitalHealth is Critical to Success" at HLTH with Galen Growth | Insights You Can Trust + FINN Partners and Ritesh Patel and Julien de Salaberry.

Many patient populations are underrepresented in clinical trials, impacting health equity. In the spirit of this year’s theme from ACRP - Association of Clinical Research Professionals, #ClinicalTrialsDay recognizes the trailblazers among us who are transforming the clinical research landscape. Learn more about the trailblazers working to ensure #diverse and #inclusive representation in clinical trials, an essential component of ensuring the safety and efficacy of new therapies. #CTD2024

How does health equity impact diverse clinical trials?

SAIA's very own Sharan K. had the privilege of attending and speaking at Patients as Partners Europe (#PatientsEU2024) a few weeks ago in London, England! She shares her experience below:   "The day was packed with insightful sessions that highlighted the importance of integrating patient engagement early in research, understanding patient preferences, and leveraging innovative solutions to reduce patient burdens. These discussions were not only informative but also inspiring, showcasing how a collaborative effort can shape a more inclusive and efficient future for clinical trials. It was an honour for me to take part in an important session on 'Debunking Myths to Advance Diversity, Equity & Inclusion in Clinical Trials'. Our incredible panel of patients & professionals underlined the crucial role of diversity in clinical trials, emphasizing how diverse populations can help accelerate medicine development and significantly improve access, inclusivity, and health equity for all patients.    This experience reinforced the vital role that patient advocacy plays in advancing healthcare. By turning patient insights into actionable strategies, we can ensure that clinical research is more representative and beneficial for all communities. A huge thank you to COUCH Health, The Conference Forum, and SAIA for providing me with this incredible opportunity to connect with industry leaders and fellow advocates. Together, we are paving the way for a more patient-centric approach to healthcare."    🏷 #PatientAdvocacy #Diversity #ClinicalTrials #PatientsAsPartners #InclusiveResearch #HealthEquity #IBDesis #SouthAsianIBDAlliance #ClinicalResearch #PatientEngagement #LogKyaKahenge #Crohns #UlcerativeColitis #IBD #Desi

Diversity in clinical trials isn't just a buzzword; it's a necessity for advancing healthcare and ensuring that treatments work for everyone. Why does diversity matter? Representation: A diverse participant pool mirrors the real-world population, ensuring treatments are effective across different ethnicities, genders, and ages. Precision Medicine: Tailoring treatments to individual needs becomes possible when we include diverse voices in research. Trust & Inclusivity: When everyone feels heard and included, it builds trust in the medical community and encourages more people to participate. Uncovering Unseen Risks: Diverse trials can uncover side effects or responses that may not be apparent in a homogenous group. Ethical Imperative: Equity in healthcare research is not just an option; it's a moral obligation.